US Stock MarketDetailed Quotes

MURA Mural Oncology

Watchlist
  • 3.385
  • +0.005+0.15%
Trading Nov 8 09:31 ET
57.67MMarket Cap-330P/E (TTM)

Mural Oncology Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-27.47%34.28M
-22.93%34.03M
6.12%196.24M
23.54%58.51M
-6.06%46.31M
47.26M
44.16M
5.45%184.92M
47.36M
49.3M
Selling and administrative expenses
42.32%6.73M
91.27%7.17M
73.17%30.71M
227.43%16.27M
31.57%5.96M
--4.73M
--3.75M
14.05%17.73M
--4.97M
--4.53M
-General and administrative expense
42.32%6.73M
91.27%7.17M
73.17%30.71M
227.43%16.27M
31.57%5.96M
--4.73M
--3.75M
14.05%17.73M
--4.97M
--4.53M
Research and development costs
-35.23%27.54M
-33.51%26.87M
-0.99%165.53M
-0.36%42.24M
-9.87%40.35M
--42.53M
--40.41M
4.61%167.19M
--42.39M
--44.77M
Operating profit
27.47%-34.28M
22.93%-34.03M
-6.12%-196.24M
-23.54%-58.51M
6.06%-46.31M
-47.26M
-44.16M
-5.45%-184.92M
-47.36M
-49.3M
Net non-operating interest income expense
Other net income (expense)
2.71M
3.12M
951K
Other non- operating income (expenses)
--2.71M
--3.12M
--951K
----
----
----
----
----
----
----
Income before tax
33.21%-31.56M
29.98%-30.92M
-5.60%-195.29M
-21.53%-57.56M
6.06%-46.31M
-47.26M
-44.16M
-5.45%-184.92M
-47.36M
-49.3M
Income tax
0
0
148.98%12.16M
61.89%1.98M
270.32%4.97M
2.91M
2.31M
7,082.35%4.88M
1.22M
1.34M
Net income
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
-8.19%-189.81M
-48.58M
-50.64M
Net income continuous Operations
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
---50.16M
---46.47M
-8.19%-189.81M
---48.58M
---50.64M
Minority interest income
Net income attributable to the parent company
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
-8.19%-189.81M
-48.58M
-50.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
37.08%-31.56M
33.46%-30.92M
-9.29%-207.45M
-22.55%-59.54M
-1.25%-51.28M
-50.16M
-46.47M
-8.19%-189.81M
-48.58M
-50.64M
Basic earnings per share
38.12%-1.86
33.92%-1.84
-9.29%-12.43
-22.54%-3.5672
-1.25%-3.0728
-3.006
-2.7844
-8.19%-11.3738
-2.9112
-3.0347
Diluted earnings per share
38.12%-1.86
33.92%-1.84
-9.29%-12.43
-22.54%-3.5672
-1.25%-3.0728
-3.006
-2.7844
-8.19%-11.3738
-2.9112
-3.0347
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -27.47%34.28M-22.93%34.03M6.12%196.24M23.54%58.51M-6.06%46.31M47.26M44.16M5.45%184.92M47.36M49.3M
Selling and administrative expenses 42.32%6.73M91.27%7.17M73.17%30.71M227.43%16.27M31.57%5.96M--4.73M--3.75M14.05%17.73M--4.97M--4.53M
-General and administrative expense 42.32%6.73M91.27%7.17M73.17%30.71M227.43%16.27M31.57%5.96M--4.73M--3.75M14.05%17.73M--4.97M--4.53M
Research and development costs -35.23%27.54M-33.51%26.87M-0.99%165.53M-0.36%42.24M-9.87%40.35M--42.53M--40.41M4.61%167.19M--42.39M--44.77M
Operating profit 27.47%-34.28M22.93%-34.03M-6.12%-196.24M-23.54%-58.51M6.06%-46.31M-47.26M-44.16M-5.45%-184.92M-47.36M-49.3M
Net non-operating interest income expense
Other net income (expense) 2.71M3.12M951K
Other non- operating income (expenses) --2.71M--3.12M--951K----------------------------
Income before tax 33.21%-31.56M29.98%-30.92M-5.60%-195.29M-21.53%-57.56M6.06%-46.31M-47.26M-44.16M-5.45%-184.92M-47.36M-49.3M
Income tax 00148.98%12.16M61.89%1.98M270.32%4.97M2.91M2.31M7,082.35%4.88M1.22M1.34M
Net income 37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M-8.19%-189.81M-48.58M-50.64M
Net income continuous Operations 37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M---50.16M---46.47M-8.19%-189.81M---48.58M---50.64M
Minority interest income
Net income attributable to the parent company 37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M-8.19%-189.81M-48.58M-50.64M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 37.08%-31.56M33.46%-30.92M-9.29%-207.45M-22.55%-59.54M-1.25%-51.28M-50.16M-46.47M-8.19%-189.81M-48.58M-50.64M
Basic earnings per share 38.12%-1.8633.92%-1.84-9.29%-12.43-22.54%-3.5672-1.25%-3.0728-3.006-2.7844-8.19%-11.3738-2.9112-3.0347
Diluted earnings per share 38.12%-1.8633.92%-1.84-9.29%-12.43-22.54%-3.5672-1.25%-3.0728-3.006-2.7844-8.19%-11.3738-2.9112-3.0347
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data